PRPH (ProPhase Labs) Long-Term Debt: $0.00 Mil (As of Dec. 2025)


What is ProPhase Labs Long-Term Debt?

ProPhase Labs PRPH -2.19% Long-Term Debt is $0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

ProPhase Labs's Long-Term Debt for the quarter that ended in Dec. 2025 was $0.00 Mil.

ProPhase Labs's quarterly Long-Term Debt declined from Jun. 2025 ($0.44 Mil) to Sep. 2025 ($0.00 Mil) but then stayed the same from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

ProPhase Labs's annual Long-Term Debt increased from Dec. 2023 ($7.33 Mil) to Dec. 2024 ($11.65 Mil) but then declined from Dec. 2024 ($11.65 Mil) to Dec. 2025 ($0.00 Mil).

ProPhase Labs  (OTCPK:PRPH) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

ProPhase Labs Long-Term Debt Related Terms

ProPhase Labs Long-Term Debt Historical Data

* Premium members only.

The historical data trend for ProPhase Labs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProPhase Labs Long-Term Debt Chart

ProPhase Labs Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.04 2.40 7.33 11.65 0.00

ProPhase Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.65 1.83 0.44 0.00 0.00
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
ProPhase Labs (PRPH) has a Long-Term Debt of $0.00 Mil as of Dec. 2025.
Is ProPhase Labs' Long-Term Debt too high?
ProPhase Labs' current Long-Term Debt is $0.00 Mil.
How does ProPhase Labs' Long-Term Debt compare to IDTA and IVRO?
ProPhase Labs' Long-Term Debt of $0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. ProPhase Labs's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProPhase Labs stock overvalued right now?
Based on GuruFocus' analysis, ProPhase Labs (PRPH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.65, compared to a current price of $0.09 — trading 85.8% below its estimated fair value. The current Long-Term Debt is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For ProPhase Labs (PRPH), the current Long-Term Debt is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProPhase Labs Business Description

Address 626 RXR Plaza, 6th Floor, Uniondale, NY, USA, 11556
ProPhase Labs Inc oriented and diversified next generation biotech, genomics and consumer products company that develops and commercializes novel drugs, dietary supplements, and compounds, and human genomic testing. It offer whole genome sequencing and related services. It maintain two operating segments: diagnostic services (which includes its COVID-19 and other diagnostic testing services) and consumer products. It generates majority of revenue from consumer products segment which engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services.